A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Blood-brain barrier (BBB) models are often used to investigate BBB function and screen brain-penetrating therapeutics, but it has been difficult to construct a human model that possesses an optimal BBB phenotype and is readily scalable. To address this challenge, we developed a human in vitro BBB model comprising brain microvascular endothelial cells (BMECs), pericytes, astrocytes and neurons derived from renewable cell sources. First, retinoic acid (RA) was used to substantially enhance BBB phenotypes in human pluripotent stem cell (hPSC)-derived BMECs, particularly through adherens junction, tight junction, and multidrug resistance protein regulation. RA-treated hPSC-derived BMECs were subsequently co-cultured with primary human brain pericytes and human astrocytes and neurons derived from human neural progenitor cells (NPCs) to yield a fully human BBB model that possessed significant tightness as measured by transendothelial electrical resistance (~5,000 Ωxcm(2)). Overall, this scalable human BBB model may enable a wide range of neuroscience studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies have shown mixed results regarding the effect of pericytes or other supporting cell types on TEER of dhBMEC monolayers [20, 33, 36, 41, 52–54].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., & Sun, H. (2007) · Science · doi:10.1126/science.1136244 · Cited by 836
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Self-citationElectrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
A cell culture model of the blood-brain barrier.
Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., & Morales, J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1725 · Cited by 765
Cited by
Items 201–300 of 547
Kadry, H., Noorani, B., Bickel, U., Abbruscato, T. J., & Cucullo, L. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00261-4 · Cited by 36
“iPSCs differentiated into brain microvascular endothelial cells (BMECs) as per the established protocol [50, 51].”
MethodResultLiterature review and appraisal on alternative neurotoxicity testing methods
Masjosthusmann, S., Barenys, M., El‐Gamal, M., Geerts, L., Gerosa, L., Gorreja, A., Kühne, B. A., Marchetti, N., Tigges, J., Viviani, B., et al. (2018) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2018.en-1410 · Cited by 35
Yamaguchi, T., Shimizu, K., Kokubu, Y., Nishijima, M., Takeda, S., Ogura, H., & Kawabata, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222113 · Cited by 35
Neurovascular dysfunction in dementia – human cellular models and molecular mechanisms
Parkes, I., Chintawar, S., & Cader, M. Z. (2018) · Clinical Science · doi:10.1042/cs20160720 · Cited by 35
Engineering Brain-Specific Pericytes from Human Pluripotent Stem Cells
Jeske, R., Albo, J., Marzano, M., Bejoy, J., & Li, Y. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0091 · Cited by 34
“PCs express receptors for pathogen-associated molecular pattern molecules, such as Toll-like receptors, which recognize bacteria and certain viruses to induce inflammatory response.84 A member of CCAAT-enhancer-binding protein (C/EBP) family, C/ EBPd, reduces expression of adhesion molecules and chemokine secretion in…”
MethodInfluentialChrysanthou, M., Estruch, I. M., Rietjens, I. M. C. M., Wichers, H. J., & Hoppenbrouwers, T. (2022) · Nutrients · doi:10.3390/nu14020363 · Cited by 34
Piantino, M., Louis, F., Shigemoto‐Mogami, Y., Nakayama-Kitamura, K., Sato, K., Yamaguchi, T., Kawabata, K., Yamamoto, S., Iwasaki, S., Hirabayashi, H., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100232 · Cited by 34
Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells
Bosworth, A. M., Faley, S. L., Bellan, L. M., & Lippmann, E. S. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00087 · Cited by 34
“Thus, using the standard iPSC-to-BMEC differentiation procedure (Lippmann et al., 2014), it was observed that BMECs differentiated from HD-iPSCs had defects in barrier formation, including diminished TEER and increased transcytosis.”
BackgroundMethodInfluentialSelf-citationIn vitro and in vivo models of BBB to evaluate brain targeting drug delivery
Sharma, B., Luhach, K., & Kulkarni, G. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00004-4 · Cited by 34
Albekairi, T. H., Vaidya, B., Patel, R., Nozohouri, S., Villalba, H., Zhang, Y., Lee, Y. S., Al-Ahmad, A. J., & Abbruscato, T. J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090467 · Cited by 33
“Stem cells have been reported to demonstrate better barrier tightness and provide high fidelity expression of BBB related transporters and receptors as compared to immortalized BBB cells models [24,25].”
ResultSelf-citationAoki, H., Yamashita, M., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00186-4 · Cited by 33
Akhtar, A. A., Sances, S., Barrett, R. J., & Breunig, J. J. (2017) · Current Stem Cell Reports · doi:10.1007/s40778-017-0080-x · Cited by 33
A guide for blood–brain barrier models
Soliman, Y., Al‐khodor, J., Koken, G. Y., & Mustafaoğlu, N. (2024) · FEBS Letters · doi:10.1002/1873-3468.15053 · Cited by 32
“The resulting RA-enhanced human BBB model exhibited a TEER value of around 5000 Ω (cid:1) cm 2 , demonstrating significant barrier tightness [245].”
Motallebnejad, P., & Azarin, S. M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00215-2 · Cited by 32
Self-citationAstrocytes and human artificial blood-brain barrier models
Zidarič, T., Gradišnik, L., & Velnar, T. (2022) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2021.6943 · Cited by 32
“In addition, the localization of claudin-5, occludin, JAMs, and ZO-1 is often a criterion for validating cell sources for in vitro models [68, 77, 79-82].”
BackgroundInfluentialRecent advances in sensor-integrated brain-on-a-chip devices for real-time brain monitoring
Zhao, C., Wang, Z., Tang, X., Qin, J., & Jiang, Z. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113431 · Cited by 32
Georgieva, J. V., Goulatis, L. I., Stutz, C. C., Canfield, S. G., Song, H. W., Gastfriend, B. D., & Shusta, E. V. (2020) · The FASEB Journal · doi:10.1096/fj.202000851r · Cited by 32
Self-citationMathew, S., Peindl, M., Neundorf, P., Dandekar, G., Metzger, M., Nickl, V., & Appelt‐Menzel, A. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04760-w · Cited by 30
“As we established a previously reported strategy to differen - tiate hiPSCs into iBCECs with high TEER [21], we aimed at combining iBCECs with GBM spheroids to reflect barrier breakdown as observed in-vivo.”
MethodResultAdvancing cardiovascular tissue engineering
Truskey, G. A. (2016) · F1000Research · doi:10.12688/f1000research.8237.1 · Cited by 30
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
Jagadeesan, S., Workman, M. J., Herland, A., Svendsen, C. N., & Vatine, G. D. (2020) · Journal of Visualized Experiments · doi:10.3791/60925 · Cited by 30
Wilson, H. K., Faubion, M. G., Hjortness, M. K., Palecek, S. P., & Shusta, E. V. (2016) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2016.0345 · Cited by 29
“differentiations upregulates several key attributes, most notably increased maximum transendothelial electrical resistance (TEER), which approaches in vivo values.(11) Much like the in vivo BBB,(14) the iPSC-BMECs do not proliferate extensively following differentiation and hence cannot be readily passaged as differen…”
Self-citationPluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy
Zink, A., Dai, D., Wittich, A., Henke, M., Pedrotti, G., Heiduschka, S., Santamaria, G., Pentimalli, T. M., Brueser, C., Notopoulou, S., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.008 · Cited by 29
Rohde, F., Danz, K., Jung, N., Wagner, S., & Windbergs, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061308 · Cited by 29
“Usually, the cultivation of these cells on Transwell® membran inserts r quires a coating consisting of collagen IV and fibronectin, co ponents of the human basement membrane, in order to enabl the adhesion and subsequent proliferation of hiPS-BCECs [16,54].”
Towards a gold standard functional readout to characterize In Vitro lung barriers
Doryab, A., & Schmid, O. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106305 · Cited by 29
Past and Current Perspectives in Modeling Bacteria and Blood–Brain Barrier Interactions
Kim, B. J., Shusta, E. V., & Doran, K. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01336 · Cited by 29
Self-citationBurgio, F., Gaiser, C., Brady, K., Gatta, V., Class, R., Schrage, R., & Suter‐Dick, L. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01404-x · Cited by 28
“Several studies have highlighted the role of other cell types in the formation of the BBB (Cecchelli et al. 2014; Lippmann et al. 2015; Canfield et al. 2017; Appelt-Menzel et al. 2017).”
BackgroundLinville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00347-7 · Cited by 28
“CD31, VE-cadherin, and GLUT-1 expression have been utilized to assess differentiation efficiency [5, 27], while RARA upregulation was previously shown to induce barrier function following iBMEC differentiation [28].”
Raasch, M., Rennert, K., Jahn, T., Gärtner, C., Schönfelder, G., Huber, O., Seiler, A. E. M., & Mosig, A. S. (2016) · Biomicrofluidics · doi:10.1063/1.4955184 · Cited by 28
Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.
Nishihara, H., & Engelhardt, B. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_407 · Cited by 15
An arduino-based sensor to measure transendothelial electrical resistance
Jones, C. G., & Chen, C. (2020) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2020.112216 · Cited by 27
Estimating Brain Permeability Using In Vitro Blood-Brain Barrier Models
Nozohouri, S., Noorani, B., Al-Ahmad, A. J., & Abbruscato, T. J. (2020) · Methods in molecular biology · doi:10.1007/7651_2020_311 · Cited by 27
Self-citationBrain Distribution of Drugs: Pharmacokinetic Considerations
Loryan, I., Hammarlund‐Udenaes, M., & Syvänen, S. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_405 · Cited by 27
Li, Y., Xia, Y., Zhu, H., Luu, E., Huang, G., Sun, Y., Sun, K., Markx, S., Leong, K. W., Xu, B., et al. (2021) · Cells · doi:10.3390/cells10102576 · Cited by 27
“are more likely to have neuro-ectodermal epithelial cell features instead of endothelial cell features [51,61].”
BackgroundResultEndres, L. M., Jungblut, M., Divyapicigil, M., Sauer, M., Stigloher, C., Christodoulides, M., Kim, B. J., & Schubert‐Unkmeir, A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00379-z · Cited by 27
“Advances in stem-cell technologies have generated model brain endothelial-like cells derived from iPSCs, which possess all relevant BEC phenotypes including endothelial markers, tight junction expression, barrier properties, response to other CNS cell types, and functional efflux transporters [11, 44, 45, 48, 49, 66].”
BackgroundMethodInfluentialYan, L., Dwiggins, C. W., Moriarty, R. A., Jung, J. W., Gupta, U., Brandon, K. D., & Stroka, K. M. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.003 · Cited by 27
Al-Ahmad, A. J., Pervaiz, I., & Karamyan, V. T. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12931 · Cited by 27
Self-citationOhtani-Kaneko, R., Sato, K., Tsutiya, A., Nakagawa, Y., 橋爪和俊, & Tazawa, H. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0229-5 · Cited by 27
Linville, R. M., DeStefano, J. G., Nerenberg, R. F., Grifno, G. N., Ye, R., Gallagher, E., & Searson, P. C. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00484 · Cited by 26
An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening
Kinarivala, N., Morsy, A., Patel, R., Carmona, A. V., Sajib, M. S., Raut, S., Mikelis, C. M., Al-Ahmad, A. J., & Trippier, P. C. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00077 · Cited by 26
Self-citationA hydrogel model of the human blood-brain barrier using differentiated stem cells
Singh, N. R., Gromnicova, R., Brachner, A., Kraev, I., Romero, I. A., Neuhaus, W., & Male, D. K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283954 · Cited by 26
“The second modification of the protocol used by other members of the Im2pact consortium [15], was preselection of high adherence cells.”
MethodInfluentialStüdle, C., Nishihara, H., Wischnewski, S., Kulsvehagen, L., Perriot, S., Ishikawa, H., Schroten, H., Frank, S., Deigendesch, N., Pasquier, R. D., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00479-4 · Cited by 26
“UMM-BMECs are phenotypically more similar to DMM-BMECs than EECM-BMECs [42, 96, 97].”
BackgroundResultGoldeman, C., Andersen, M. V., Al-Robai, A., Buchholtz, T., Svane, N., Ozgür, B., Holst, B., Shusta, E. V., Hall, V. J., Saaby, L., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105577 · Cited by 26
Self-citationBosworth, A. M., Kim, H., O’Grady, K. P., Richter, I., Lee, L. H., O’Grady, B. J., & Lippmann, E. S. (2021) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-021-00706-8 · Cited by 25
Self-citationNoorani, B., Chowdhury, E. A., Alqahtani, F., Ahn, Y., Nozohouri, E., Zoubi, S., Patel, D., Wood, L. M., Huang, J., Siddique, M. B., et al. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001281 · Cited by 25
Self-citationPage, S., Patel, R., Raut, S., & Al-Ahmad, A. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.009 · Cited by 25
Self-citationMochizuki, T., Mizuno, T., Kurosawa, T., Yamaguchi, T., Higuchi, K., Tega, Y., Nozaki, Y., Kawabata, K., Deguchi, Y., & Kusuhara, H. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000115 · Cited by 25
“The differentiation to hiPS-BMECs was conducted as described previously (Lippmann et al., 2012, 2014; Kurosawa et al., 2018).”
Differential Effects of Retinoic Acid Concentrations in Regulating Blood–Brain Barrier Properties
Bonney, S. K., & Siegenthaler, J. A. (2017) · eNeuro · doi:10.1523/eneuro.0378-16.2017 · Cited by 25
“Additionally, -catenin is required for stabilization of AJs by interacting with VE-cadherin (Liebner et al. 2008; Zhou and Nathans 2014; Zhou et al. 2014).”
BackgroundModeling Human Brain Tumors and the Microenvironment Using Induced Pluripotent Stem Cells
Khamis, Z. I., Sarker, D. B., Xue, Y., Al-Akkary, N., James, V. D., Zeng, C., Li, Y., & Sang, Q. A. (2023) · Cancers · doi:10.3390/cancers15041253 · Cited by 24
Modular tissue-in-a-CUBE platform to model blood-brain barrier (BBB) and brain interaction
Koh, I., & Hagiwara, M. (2024) · Communications Biology · doi:10.1038/s42003-024-05857-8 · Cited by 24
Wasielewska, J. M., Chaves, J. C. S., Cabral-da-Silva, M. C., Pecoraro, M., Viljoen, S. J., Nguyen, T. H., Bella, V. L., Oikari, L. E., Ooi, L., & White, A. R. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00565-1 · Cited by 24
“Following seeding densities were used in specified culture vessel formats: 24 well plate: 5 × 10 5 cells per well, 0.4 μm pore Transwell insert: 3 × 10 5 cells per Transwell, 3.0 μm pore Transwell insert: 4.5 × 10 5 cells per Transwell, as previously optimised by us and others [34, 36–40].”
MethodInfluentialAppelt‐Menzel, A., Cubukova, A., & Metzger, M. (2018) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.62 · Cited by 24
Cheng, Y., Medina, A., Yao, Z., Basu, M., Natekar, J. P., Lang, J., Sanchez, E., Nkembo, M., Xu, C., Qian, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110885 · Cited by 24
“…TEER values in the range of 600–2,000 U .cm 2 (Lippmann et al., 2012, 2014; Oh-shima et al., 2019) but complex cocultures that include additional components, such as pericytes and neurons, can produce values over 5,000 U .cm 2 (Hollmann et al., 2017; Lippmann et al., 2014; Neal et al., 2019).”
Ozgür, B., Puris, E., Brachner, A., Appelt‐Menzel, A., Oerter, S., Balzer, V., Holst, M. R., Christiansen, R. F., Hyldig, K., Buckley, S. T., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00501-9 · Cited by 23
“This also applies to other BBB models based on hIPSC cell lines [16–22].”
BackgroundMethodInfluentialDing, Y., Palecek, S. P., & Shusta, E. V. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00580-2 · Cited by 23
“Established protocols [64, 65, 68] were used to differentiate isogenic iPSC cell lines with homozygous APOE2 , APOE3 , APOE4 or APOE Knockout ( APOE KO ) isoforms into BMEC-like cells.”
MethodSelf-citationMotallebnejad, P., Rajesh, V. V., & Azarin, S. M. (2021) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-021-00710-y · Cited by 23
Self-citationGetting closer to modeling the gut-brain axis using induced pluripotent stem cells
Hall, V. J., & Bendtsen, K. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146062 · Cited by 23
“There has been a fast development from simpler BBB models using monocultures of brain microvascular endothelial cells, such as the immortalized human cerebral endothelial cell line hCMEC/D3, to subsequent developments of co-cultures with astrocytes, pericytes, and neurons (Lippmann et al., 2014; Yamamizu et al., 2017).”
MethodJamieson, J. J., Lin, Y., Malloy, N. A., Soto, D., Searson, P. C., & Gerecht, S. (2022) · The FASEB Journal · doi:10.1096/fj.202200010rr · Cited by 22
Gallagher, E., Minn, I., Chambers, J. E., & Searson, P. C. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0035-0 · Cited by 22
Mantle, J. L., & Lee, K. H. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26967 · Cited by 22
Differentiation of Brain Pericyte‐Like Cells from Human Pluripotent Stem Cell−Derived Neural Crest
Gastfriend, B. D., Stebbins, M. J., Du, F., Shusta, E. V., & Palecek, S. P. (2021) · Current Protocols · doi:10.1002/cpz1.21 · Cited by 22
Self-citationSong, L., Yan, Y., Marzano, M., & Li, Y. (2019) · Cells · doi:10.3390/cells8040299 · Cited by 22
Tissue-engineered blood vessels as promising tools for testing drug toxicity
Truskey, G. A., & Fernandez, C. E. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1047342 · Cited by 22
“Some recent results with endothelial cells derived from iPS cells provide one strategy to promote differentiation of endothelial cells with highly specialized barrier function [9].”
Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist
Sanai, N. (2019) · Neurosurgery · doi:10.1093/neuros/nyz218 · Cited by 21
“tissue15; (3) develop a novel imaging probe and evaluate its distribution, binding characteristics, and target effects in humans16; (4) evaluate the human pharmacodynamics (PD) and/or pharmacokinetics (PK) of 2 or more analogs to select the most promising candidate for further development17; (5) determine a dose range…”
BackgroundMethodAragón-González, A., Shaw, A. C., Kok, J. R., Roussel, F. S., Souza, C. D. S., Granger, S. M., Vetter, T. A., de Diego‐Otero, Y., Meyer, K., Beal, S. N., et al. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00528-6 · Cited by 20
“Brain endothelial-like cells (BMEC-like cells) were generated by culturing human induced pluripotent stem cells (hi-PSCs) in mTeSR plus media (STEMCELL Technologies) on Matrigel-coated (Corning) plates as previously described by Lippmann and Neal et al. protocols [19, 47, 48].”
MethodLowenthal, J., & Gerecht, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.127 · Cited by 20
“Models of the bloodebrain barrier fabricated entirely from stem cell sources have shown promise over primary cell culture for advanced cerebrovascular modeling [54,55].”
BackgroundTheile, M., Wiora, L., Russ, D., Reuter, J., Ishikawa, H., Schwerk, C., Schroten, H., & Mogk, S. (2019) · Journal of Visualized Experiments · doi:10.3791/60087 · Cited by 20
Williams, L. M., Fujimoto, T., Weaver, R. R., Logsdon, A. F., Wilson, M., Evitts, K. M., Young, J. E., Banks, W. A., & Erickson, M. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00307-1 · Cited by 20
Extracellular matrix proteins in construction and function of in vitro blood-brain barrier models
Du, F., Shusta, E. V., & Palecek, S. P. (2023) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2023.1130127 · Cited by 20
Self-citationApáti, Á., Varga, N., Berecz, T., Erdei, Z., Homolya, L., & Sarkadi, B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1558207 · Cited by 19
“Lippmann and colleagues [119] applied hPSC-derived brain microvascular endothelial cells cocultured with primary human brain pericytes, as well as with human”
BackgroundTransplantation of iPS‐derived vascular endothelial cells improves white matter ischemic damage
Xu, B., Kurachi, M., Shimauchi‐Ohtaki, H., Yoshimoto, Y., & Ishizaki, Y. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14949 · Cited by 19
“Among them we adopted the method established by Lippmann and others (Lippmann et al., 2014, 2012).”
MethodModeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease
Wasielewska, J. M., Chaves, J., White, A. R., & Oikari, L. E. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch7 · Cited by 19
“Co-cultures are achieved by culturing other BBB cells, such as pericytes or astrocytes, in the surrounding well, in which the BEC containing Transwell insert is placed, or on the underside of the BEC containing Transwell insert (Figure 3A) (63, 69).”
BackgroundInfluentialA Hybrid Nanofiber/Paper Cell Culture Platform for Building a 3D Blood–Brain Barrier Model
Huang, K., Castiaux, A. D., Podicheti, R., Rusch, D. B., Martin, R. S., & Baker, L. A. (2021) · Small Methods · doi:10.1002/smtd.202100592 · Cited by 19
Brain Microvascular Pericytes—More than Bystanders in Breast Cancer Brain Metastasis
Ippolitov, D., Arreza, L., Munir, M. N., & Hombach‐Klonisch, S. (2022) · Cells · doi:10.3390/cells11081263 · Cited by 19
Girard, S. D., Julien‐Gau, I., Molino, Y., Combes, B. F., Greetham, L., Khrestchatisky, M., & Nivet, E. (2023) · The FASEB Journal · doi:10.1096/fj.202201422r · Cited by 18
“These authors reported that their procedure is based on PSCs co-differentiation into both neural and endothelial lineages providing an “embryonic brain-like microenvironment” allowing the specification of ECs into BMVECs via a Wnt/β-catenin signaling (Lippmann et al., 2012).”
BackgroundMethodResultInfluentialHuman Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development
Lin, X., Tang, J., & Lou, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14060525 · Cited by 18
“The models of neurons that have been differentiated from hiPSCs include the dopaminergic neuron model [135], the cholinergic neuron model [136], the astrocyte model [137], and models of the blood–brain barrier [138].”
MethodPharmaceutical iron formulations do not cross a model of the human blood-brain barrier
Chiou, B., Neal, E. H., Bowman, A. B., Lippmann, E. S., Simpson, I. A., & Connor, J. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198775 · Cited by 17
Self-citationMultilayered microcasting of agarose–collagen composites for neurovascular modeling
Heidari, H., & Taylor, H. (2019) · Bioprinting · doi:10.1016/j.bprint.2019.e00069 · Cited by 17
Martinelli, I., Tayebati, S. K., Tomassoni, D., Nittari, G., Roy, P., & Amenta, F. (2022) · Cells · doi:10.3390/cells11071120 · Cited by 18
Zhang, W., Zhao, X., Qi, X., Kimber, S. J., Hooper, N. M., & Wang, T. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1195470 · Cited by 17
Current overview of induced pluripotent stem cell-based blood-brain barrier-on-a-chip
Alves, A. H., Nucci, M. P., Valle, N. M. E., Missina, J. M., Mamani, J. B., Rego, G. N. A., Dias, O. F. M., Garrigós, M. M., Oliveira, F. A., & Gamarra, L. F. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i6.632 · Cited by 16
Reconstitution of human tissue barrier function for precision and personalized medicine
Kim, J., Yoon, T., Lee, S. W., Kim, P. J., & Kim, Y. (2024) · Lab on a Chip · doi:10.1039/d4lc00104d · Cited by 16
Neal, E. H., Katdare, K. A., Shi, Y., Marinelli, N. A., Hagerla, K. A., & Lippmann, E. S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15532 · Cited by 16
Self-citationMicrofluidic strategies for the blood-brain barrier construction and assessment
Yin, F., Su, W., Wang, L., & Hu, Q. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116689 · Cited by 16
Espinal, E. R., Sharp, S. J., & Kim, B. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_4 · Cited by 16
Pervaiz, I., Zahra, F. T., Mikelis, C. M., & Al-Ahmad, A. J. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15684 · Cited by 16
Self-citationOchocinska, M. J., Zloković, B. V., Searson, P. C., Crowder, A. T., Kraig, R. P., Ljubimova, J. Y., Mainprize, T. G., Banks, W. A., Warren, R. Q., Kindzelski, A., et al. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0061-6 · Cited by 16
Choi, J., Mathew, S., Oerter, S., Appelt‐Menzel, A., Hansmann, J., & Schmitz, T. (2022) · Bioengineering · doi:10.3390/bioengineering9010039 · Cited by 16
Schmitz, T., Schweinlin, M., Kollhoff, R. T., Engelhardt, L., Lotz, C., Groeber-Becker, F. K., Walles, H., Metzger, M., & Hansmann, J. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b00345 · Cited by 16
Qiu, B., Pompe, S., Xenaki, K. T., Maggio, A. D., Henegouwen, P. M. P. V. B. E., Oliveira, S., Mastrobattista, E., & Caiazzo, M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114257 · Cited by 15
Gokce, C., Altun, B., Kirit, E., Yavuz, H., Uyar, R., Çelik, D., & Yılmazer, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106961 · Cited by 15
Organotypic Neurovascular Models: Past Results and Future Directions
Balikov, D. A., Neal, E. H., & Lippmann, E. S. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.010 · Cited by 15
Self-citationShi, Y., Kim, H., Hamann, C. A., Rhea, E. M., Brunger, J. M., & Lippmann, E. S. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00375-3 · Cited by 15
“Moreover, nuclear receptor signaling influences the development, maintenance, and function of the BBB [18, 40, 41].”
BackgroundSelf-citationZhang, H., Yamaguchi, T., & Kawabata, K. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00408-5 · Cited by 15
“The unique properties of BBB, including high TEER values, normal tube formation, expression of specific transporters, and LDL uptake was acquired by treating the cells with retinoic acid [2, 3].”
BackgroundMethodWhat human blood-brain barrier models can tell us about BBB function and drug discovery?
Ferreira, L. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1646722 · Cited by 15
Sourcing cells for in vitro models of human vascular barriers of inflammation
McCloskey, M. C., Zhang, V. Z., Ahmad, S. D., Walker, S. N., Romanick, S., Awad, H. A., & McGrath, J. L. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.979768 · Cited by 14
“Future iterations transitioned from undefined to defined medium and introduced retinoic acid to improve barrier properties (110).”
BackgroundPong, S., Lizano, P. L., & Karmacharya, R. (2020) · Journal of Visualized Experiments · doi:10.3791/61629 · Cited by 14
Lin, M. H., Chung, C., Chen, K.-T., Yeh, J., Lee, T., Lee, M., Lee, I., Huang, W.-C., & Yang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010182 · Cited by 14
Xiang, J., Andjelkovic, A. V., Zhou, N., Hua, Y., Xi, G., Wang, M. M., & Keep, R. F. (2018) · PubMed · Cited by 14
Heinzelman, P., Schoborg, J. A., & Jewett, M. C. (2015) · Protein Engineering Design and Selection · doi:10.1093/protein/gzv022 · Cited by 14
Takeuchi, L. E., Kalia, L. V., & Simmons, C. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106864 · Cited by 13
“…Muratore et al., 2014; Ortiz-Virumbrales et al., 2017; Canfield et al., 2019; Wang et al., 2018; Woodruff et al., 2016) ECs, (Katt et al., 2025; Lippmann et al., 2014; Luo et al., 2024; Stebbins et al., 2018; Qian et al., 2017) microglia, (Abud et al., 2017; Douvaras et al., 2017; Konttinen et…”
Metadata
- Authors
- Lippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Palecek, Sean P.
- Shusta, Eric V.
- Venue
- Scientific Reports
- Published
- 2014-02-24
- Volume
- 4
- Issue
- 1
- Pages
- 4160-4160
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3932448
- OpenAlex
- W2042883482
- Cited by
- 508
- References
- 51
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 45 · 2023: 55 · 2022: 56 · 2021: 45 · 2020: 58 · 2019: 54 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 22 · 2014: 10
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (NS083688)
- Cedars-Sinai Medical Center
- Beijing Municipal Education Commission
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (AA020476, RC4AA020476)
- National Cancer Institute (P30CA014520)
- National Institute of General Medical Sciences (T32GM008505)
- National Institute of Neurological Disorders and Stroke (R01NS083688, NS083688)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- blood-brain barrier model, retinoic acid, human pluripotent stem cells, brain microvascular endothelial cells, pericytes, astrocytes, neural progenitor cells, tight junctions, adherens junctions, multidrug resistance protein, transendothelial electrical resistance, co-culture
- MeSH terms
- Astrocytes, Blood-Brain Barrier, Brain, Cell Differentiation, Cells, Cultured, Electric Conductivity, Endothelium, Vascular, Humans, Models, Biological, Neurons, Tretinoin, Coculture Techniques, Pericytes, Pluripotent Stem Cells, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.